Reckitt Benckiser Group plc
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Kris Licht
- Full Time Employees
- 38,100
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- Address
- Turner House Slough BR United Kingdom SL1 3UH
- IPO Date
- Oct 15, 2008
- CIK
- 0001420798
- Website
- reckitt.com
- Similar Companies
- Business
- Reckitt Benckiser Group plc is a British multinational consumer goods company primarily engaged in the manufacture and sale of health, hygiene, and nutrition products. Founded through the merger of Reckitt & Colman plc and Benckiser NV in 1999, the company is headquartered in Slough, United Kingdom, and operates globally with products sold in nearly 200 countries. Reckitt organizes its business into three main segments: Health, Hygiene, and Nutrition. The Health segment offers over-the-counter (OTC) pharmaceuticals including pain relief, gastrointestinal and respiratory products, germ protection solutions, vitamins, minerals and supplements (VMS), intimate wellness, and personal care products. Its Hygiene segment includes categories such as surface and disinfection, auto dishwasher products, air care, fabric additives, and lavatory care. The Nutrition segment focuses on infant and child nutrition and specialized nutritional solutions. In recent major developments, Reckitt has embarked on a strategic overhaul to sharpen its portfolio focusing on high-growth, high-margin "Powerbrands" while planning to exit its Essential Home business, which includes several homecare brands, by the end of 2025. This strategy aims to simplify its organizational structure from a global business unit model to a unified category structure operating through three geographic regions: North America, Europe, and Emerging Markets. The company pursues operational efficiency with initiatives to reduce fixed costs by at least 300 basis points by 2027 and has announced a substantial £1 billion share buyback program. Reckitt continues investing in innovation and market execution while enhancing its supply chain resilience and R&D capabilities. Recent performance reflects resilience in Health and Hygiene segments despite challenging conditions, with management targeting accelerated growth and margin expansion through brand focus and efficiency improvements. Reckitt’s portfolio includes well-known global brands such as Dettol, Lysol, Finish, Vanish, Durex, Nurofen, and Strepsils. The company serves retail and fast-moving consumer goods (FMCG) markets worldwide through a global distribution network comprising 131 distribution and embellishment centers across 51 countries. Reckitt employs over 35,000 people worldwide and generated revenue of approximately $18 billion in 2024, maintaining a significant presence across key markets including the US, UK, Europe, and emerging markets. This strategic realignment positions Reckitt as a focused consumer health and hygiene leader with an emphasis on innovation, brand strength, and operational excellence.
Company News
How a Western Consumer Giant Is Thriving on China's Social-Media Shoppers
Reckitt Benckiser Group PLC (OTCMKTS:RBGLY) Receives Average Recommendation of “Moderate Buy” from Analysts
Reckitt Benckiser Group (OTCMKTS:RBGLY) Shares Gap Up – Time to Buy?
Reckitt faces mixed broker forecasts ahead of third-quarter update
Reckitt Benckiser Group (OTCMKTS:RBGLY) Share Price Breaks Below Two Hundred Day Moving Average – What’s Next?
Lysol and Mucinex Maker Reckitt Expands U.S. Manufacturing
Reckitt Benckiser Group PLC (OTCMKTS:RBGLY) Given Average Recommendation of “Moderate Buy” by Analysts
Reckitt Benckiser Group plc (RBGLY) Presents at Barclays 19th Annual Global Consumer Staples Conference Transcript
Reckitt Benckiser shares rise over 4% as JP Morgan upgrades to 'overweight'
3 Cheap International Stocks to Buy
First Bellwether Trial Today Against Reckitt Benckiser's Mead Johnson in NEC Baby Formula MDL Led by Levin Papantonio
Reckitt Benckiser: Core Brands Remain Undervalued Despite Mead Johnson Litigation Risk
Reckitt Benckiser Group: A Solid Quarter Supports The Investment Case
Reckitt Benckiser Group plc (RBGLY) Q2 2026 Earnings Call Transcript
Reckitt Benckiser Group H1 Earnings Call Highlights
Lysol Maker Reckitt Issues New $664 Million Share Buyback
Reckitt launches £500m buyback as quarterly sales accelerate
Reckitt beats second-quarter sales estimates on emerging markets strength
Lysol Maker Reckitt to Offload Sanctions-Hit Russian Hygiene Business
UK's Reckitt to sell Russian hygiene business